Efficacy and safety of the once-weekly GLP-1 receptor agonist albiglutide versus sitagliptin in patients with type 2 diabetes and renal impairment: a randomized phase III study. (Q51318574)
Jump to navigation
Jump to search
scientific article published on 21 July 2014
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Efficacy and safety of the once-weekly GLP-1 receptor agonist albiglutide versus sitagliptin in patients with type 2 diabetes and renal impairment: a randomized phase III study. |
scientific article published on 21 July 2014 |
Statements
1 reference
Efficacy and safety of the once-weekly GLP-1 receptor agonist albiglutide versus sitagliptin in patients with type 2 diabetes and renal impairment: a randomized phase III study. (English)
1 reference
Lawrence A Leiter
1 reference
Molly C Carr
1 reference
Murray Stewart
1 reference
Angela Jones-Leone
1 reference
Rhona Scott
1 reference
Fred Yang
1 reference
Yehuda Handelsman
1 reference
21 July 2014
1 reference
1 reference
37
1 reference
10
1 reference
2723-2730
1 reference
Identifiers
1 reference
1 reference